The Berlin School of Integrative Oncology (BSIO) is a joint graduate school of the Charité University Hospital, Humboldt University, Free University and non-university research institutions dedicated to cancer research in an international context.
The BSIO aims to elucidate the individual molecular tumor and patient characteristics via advanced experimental models and novel diagnostics. This will allow innovative customized therapy plans and addresses the current challenges of personalized cancer medicine.
It is the central mission of the inter- transdisciplinary graduate school to introduce basic scientists to the most demanding problems in clinical oncology, and, in turn, to stimulate young research-interested clinicians to translate unsolved clinical challenges into experimentally approachable questions, ultimately leading to their mechanistic explanation.
It is the believe and vision of the BSIO that only best trained scientists and clinicians capable of seamlessly communicating with each other will succeed together to overcome therapeutic barriers to elimination of cancer by cooperatively developing therapeutic solutions.